Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo
Information source: St. Louis University
Information obtained from ClinicalTrials.gov on December 08, 2011 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Seborrheic Dermatitis
Intervention: ketoconazole 2% foam (Drug); ketoconazole 2% shampoo (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: St. Louis University Official(s) and/or principal investigator(s): Mary Guo, M.D., Study Director, Affiliation: St. Louis University Dermatology Scott W Fosko, M.D., Study Chair, Affiliation: St. Louis University Dermatology Jeaneen A Chappell, M.D., Principal Investigator, Affiliation: St. Louis University Dermatology
Overall contact: Jeaneen A Chappell, MD, Phone: 314-256-3439, Email: jchappe1@slu.edu
Summary
The aims of this study are to compare the effectiveness of antifungal foam versus antifungal
shampoo and determine patient compliance and satisfaction with both vehicles among African
American females with dandruff practicing less than once weekly hair washing.
Clinical Details
Official title: Seborrheic Dermatitis of the Scalp in Populations Practicing Less Frequent Hair Washing: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Total Dandruff Severity Score (TDSS)
Secondary outcome: CompliancePatient Satisfaction Additional Improvement in the Total Dandruff Severity Score (TDSS)
Detailed description:
A wide variety of topical vehicles are available for medications that treat scalp disorders.
Proper vehicle selection is important when managing scalp conditions, such as seborrheic
dermatitis, because the efficacy of these treatments depends largely on compliance and the
amount of active ingredient delivered to the scalp. It is therefore important to prescribe
vehicles that are easy to apply and cause the least amount of disruption to the patients'
pre-existing hair care practices. One of the most common rate limiting hair care practices
among different cultures is wash frequency. Literature shows African American women are
more likely to wash their hair less than once weekly versus Caucasian women. We hypothesize
certain vehicles, such as foam preparations which do not require hair washing, will be more
efficacious in African American women with seborrheic dermatitis than shampoo preparations.
Eligibility
Minimum age: 18 Years.
Maximum age: 89 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- African American females aged 18 to 89 years
- Previous diagnosis of seborrheic dermatitis of the scalp
- TDSS between 50 and 200
- Practice less than or equal to once weekly hair washing
- Immunocompetent
- Willing to not grease or oil scalp
Exclusion Criteria:
- Age below 18 years or above 89 years
- Medical history of psoriasis, diabetes mellitus, immunosuppression, neurologic
disorders, and/or chronic disease not stabilized by medication
- Patients taking any oral steroids and/or antifungals within 30 days of enrollment
- Sensitivity to any formulation components of either ketoconazole foam or shampoo
including sulfur
- The use of any topical medications including over the counter products indicated for
the treatment of seborrheic dermatitis within 14 days of enrollment
- Pregnant women, women who plan on becoming pregnant, or breastfeeding women
- Current use or history of using any biologic medication
Locations and Contacts
Jeaneen A Chappell, MD, Phone: 314-256-3439, Email: jchappe1@slu.edu
St. Louis University Department of Dermatology, St. Louis, Missouri 63104, United States; Recruiting Jeaneen A Chappell, MD, Phone: 314-256-3439, Email: jchappe1@slu.edu Rosemary King, PA, Phone: 314-256-3436, Email: kingrm@slu.edu Jeaneen A Chappell, MD, Principal Investigator
Additional Information
Starting date: September 2010
Last updated: September 21, 2010
|